Dorzolamide Hydrochloride And Timolol Maleate Preservative Free Solution/ Drops
Product Images NDC 65862-947

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Dorzolamide Hydrochloride And Timolol Maleate Preservative Free (NDC 65862-947). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Dorzolamide Timolol Fig1)

FDA Label Image

Figure B (Dorzolamide Timolol Fig2)

FDA Label Image

Figure C (Dorzolamide Timolol Fig3)

FDA Label Image

Figure D (Dorzolamide Timolol Fig4)

FDA Label Image

Package Label-principal Display Panel (2%/0.5% (BFS LDPE Vial Label))

Package Label-principal Display Panel (2%/0.5% (BFS LDPE Vial Label))
Dorzolamide HCI and Timolol Maleate ophthalmic solution is a prescription only medication that is used in the eye. It is manufactured in India by Aurobindo Pharma and is preservative free. The product code for this solution is P1417125.*
FDA Label Image

Package Label-principal Display Panel (2%/0.5% (Pouch Label)

Package Label-principal Display Panel (2%/0.5% (Pouch Label)
This is a description of a medication for the eyes, containing Dorzolamide Hydrochloride and Timolol Maleate, used for treating glaucoma or high pressure inside the eyes. The medication is available in the form of 15 single-use containers, each containing 0.2 mL of ophthalmic solution. The solution should be used immediately after opening the container and discarded after each use. The package contains inactive ingredients such as hygroscopic cellulose, mannitol, and sodium hydroxide. The dosage information and storage instructions are provided on the package insert. This medication is distributed by Aurobindo Pharma USA Inc. and made in India.*
FDA Label Image

Package Label-principal Display Panel (2%/0.5% (Container-Carton)

Package Label-principal Display Panel (2%/0.5% (Container-Carton)
This is a description of a drug called Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution. It is a prescription-only, preservative-free eye medication used for treating high pressure inside the eye in individuals with ocular hypertension and open-angle glaucoma. It is recommended to apply one drop in the morning and evening in the affected eye(s). The product comes with 60 single-use containers, with four pouches of fifteen containers, and each container contains 0.2 mL of solution. The inactive ingredients in the product are hydrowyethyl cellulose, mannitol, sodium citrate dihydrate, sodium hydroxide, and water for injection. The product should be stored at a controlled room temperature and should not be frozen. Any unused container must be discarded after 15 days from opening a pouch. The product is distributed by Aurobindo Pharma USA, Inc., and it is made in India.*
FDA Label Image

Package Label-principal Display Panel (2%/0.5% (Carton Label)

Package Label-principal Display Panel (2%/0.5% (Carton Label)
This is a description of a Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution, which is a preservative-free medication applied topically in the eye. It comes in 180 single-use containers, containing different amounts of active and inactive ingredients, with a usual dosage of one drop in the morning and evening for affected eyes. The containers should be disposed of after use, and storage should be done at 20° to 25°C.*
FDA Label Image

Chemical Structure (Dorzolamide Timolol Str1)

FDA Label Image

Chemical Structure (Dorzolamide Timolol Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.